The Carlyle Group Operating Cash Flow decreased by 4.0% to -$1.24B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 252.9%, from -$352.10M to -$1.24B. Over 2 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a 35.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $525.80M | $707.10M | $488.60M | -$371.70M | -$186.80M | -$120.80M | -$112.50M | -$736.50M | $799.80M | $254.10M | $71.10M | -$1.27B | -$352.80M | -$352.10M | -$168.80M | -$1.56B | -$1.20B | -$1.24B |
| QoQ Change | — | +34.5% | -30.9% | -176.1% | +49.7% | +35.3% | +6.9% | -554.7% | +208.6% | -68.2% | -72.0% | <-999% | +72.2% | +0.2% | +52.1% | -823.9% | +23.4% | -4.0% |
| YoY Change | — | — | — | — | -135.5% | -124.7% | +69.7% | -294.3% | — | +310.3% | +163.2% | -72.4% | -238.8% | -595.2% | +86.7% | — | -238.7% | -252.9% |